Bioequivalence Study of Sorafenib Tablet and Nexavar

NCT02599337 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Nexavar
DRUG: Sorafenib

Sponsor

Yabao Pharmaceutical Group